Results Healthcare   |   Results International

CROs and CMOs

We work with CROs and CMOs in organisation asset restructuring and building core divisions through M&A activity.

CROs and CMOs

Clinical/contract research organisations (CROs) in particular are among the strongest growth sectors of the pharmaceutical industry, with many firms across the sector experiencing double- digit annual growth. This growth is driven by the trend for increased outsourcing by pharmaceutical and biotechnology companies looking to shift fixed to variable costs and access specialist capabilities not found in-house, and an overall increase in biopharmaceutical R&D spending. CROs have also become one of the most active sectors for M&A, with larger players consolidating to achieve critical mass, as well as completing bolt-on acquisitions to offer a more comprehensive service offering.

Our team has a strong track-record in successful CRO transactions.

09 Jul 2020

Deal activity and valuations in the healthcare sector during COVID-19

There has been a measurable impact on healthcare deal activity and valuations as a result of COVID-19. Major equity indices…

15 Jun 2020

CRO Sector Update: June 2020

The impact of COVID-19 on M&A and valuations in the CRO sector Unsurprisingly, the CRO market, like many other sectors…

Subscribe to receive our latest sector-specific research on M&A activity and fundraisings:

16 Jul 2020 - 3pm-4pm (BST - UK), 10am-11am (ET - NY)

Webinar: The outlook for Children’s Services post-COVID-19

Children’s Services has been one of the more resilient areas within UK care over the last 2 years, and also…

Insights

Weekly Public Healthcare Sector Analysis, News, Blogs & White Papers

View our insights     SUBSCRIBE

Connect with us

Follow Results Healthcare on Twitter Follow Results Healthcare on LinkedIn

Your Nearest Office